Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

5.1K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.1K
Autophagic Cell Death01:18

Autophagic Cell Death

4.5K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.5K
Overview of Cell Death01:30

Overview of Cell Death

9.8K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.8K
Emerging Adulthood01:27

Emerging Adulthood

663
Jeffrey Arnett's concept of emerging adulthood offers a framework to understand the unique developmental stage between adolescence and full-fledged adulthood, generally from ages 18 to 25. This period is marked by extensive exploration and shifts in identity, relationships, and career choices, a process known in psychology as role experimentation. Emerging adulthood reflects the evolving cultural expectations surrounding adulthood and the dynamic process of personal transformation during...
663
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

8.4K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

8.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TRPM7 and magnesium orchestrate human CD4 T-cell activation and differentiation.

Life science alliance·2025
Same author

Inter-Organellar Ca<sup>2+</sup> Homeostasis in Plant and Animal Systems.

Cells·2025
Same author

Thapsigargin triggers a non-apoptotic, caspase-independent programmed cell death in basophilic leukaemia cells.

Cell death discovery·2025
Same author

TRPM7 activity drives human CD4 T-cell activation and differentiation in a magnesium dependent manner.

bioRxiv : the preprint server for biology·2024
Same author

Lipid-nanoparticle-induced vacuolization in microglia.

Communications biology·2024
Same author

Inactivation of TRPM7 Kinase Targets AKT Signaling and Cyclooxygenase-2 Expression in Human CML Cells.

Function (Oxford, England)·2023

Related Experiment Video

Updated: Jan 29, 2026

Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells
12:44

Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells

Published on: October 11, 2012

23.9K

Non-Apoptotic Programmed Cell Death: From Ultrastructural Characterization to Emerging Therapeutic Opportunities.

Philip Steiner1, Lena Wiesbauer1, Hubert H Kerschbaum2

  • 1Institute of Pharmacology, Faculty of Medicine, Johannes Kepler University Linz, 4020 Linz, Austria.

Cells
|January 28, 2026
PubMed
Summary

Exploring non-apoptotic programmed cell death (PCD) pathways like ferroptosis and necroptosis is vital. Understanding these cell death mechanisms offers new therapeutic targets for cancer and neurodegenerative diseases.

Keywords:
autophagyautosiscancercaspase-independent cell deathferroptosisneurodegenerative diseasesnon-apoptotic cell deathprogrammed cell deathregulated cell deathultrastructure

More Related Videos

Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria
08:22

Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria

Published on: May 16, 2025

571
Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
09:01

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Published on: September 27, 2013

11.5K

Related Experiment Videos

Last Updated: Jan 29, 2026

Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells
12:44

Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells

Published on: October 11, 2012

23.9K
Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria
08:22

Studying Copper Nanoparticle-Induced Programmed Cell Death in Bacteria

Published on: May 16, 2025

571
Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
09:01

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Published on: September 27, 2013

11.5K

Area of Science:

  • Biochemistry and Molecular Biology
  • Cell Biology
  • Pathology

Background:

  • Non-apoptotic programmed cell death (PCD) pathways are crucial in health and disease.
  • These pathways, including ferroptosis, necroptosis, pyroptosis, autophagy, paraptosis, cuproptosis, disulfidptosis, and erebosis, have distinct molecular and ultrastructural features.
  • Dysregulation of PCD is implicated in various pathologies, including cancer, neurodegeneration, and inflammation.

Purpose of the Study:

  • To provide a comprehensive review of distinct non-apoptotic programmed cell death modalities.
  • To detail the unique molecular signaling, ultrastructural characteristics, and functional outcomes of each PCD pathway.
  • To facilitate the morphological identification of these cell death forms and highlight their therapeutic potential.

Main Methods:

  • Literature review and synthesis of existing research on non-apoptotic PCD.
  • Detailed characterization of cellular and subcellular hallmarks for each PCD modality.
  • Schematic visualization of the identified hallmarks.

Main Results:

  • Identification and characterization of multiple non-apoptotic PCD pathways (ferroptosis, necroptosis, pyroptosis, autophagy, paraptosis, cuproptosis, disulfidptosis, erebosis).
  • Elucidation of distinct molecular signatures and ultrastructural features differentiating these pathways from apoptosis.
  • Highlighting the potential of targeting these pathways for therapeutic interventions.

Conclusions:

  • Understanding the diverse non-apoptotic PCD pathways is essential for developing novel therapeutic strategies.
  • Targeting specific PCD cascades offers promise for overcoming apoptosis resistance in cancer therapy.
  • Inhibiting cell death in critical tissues like the myocardium and nervous system is key for cytoprotection in neurodegenerative and inflammatory diseases.